SEC Tracker
Get the app

TransMedics Group TMDX

TransMedics Group reports $203.01 million revenue for Q3 2026

Form
10-Q
Filed
Importance
Notable
  1. Revenue: $203.01 million for the three months ended Sep 30, 2026
  2. Net income: $17.07 million for the three months ended Sep 30, 2026
  3. Diluted EPS: $0.46 for the three months ended Sep 30, 2026
  4. Cash and equivalents: $511.4 million at Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when TransMedics Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

  1. Integer Holdings ITGR public float $4.3B, Jun 27, 2025
  2. iRhythm Holdings IRTC public float $4.9B, Jun 30, 2025
  3. Masimo MASI public float $3.9B, Jun 28, 2025
  4. Inspire Medical Systems INSP public float $3.8B, Jun 30, 2025
  5. Merit Medical Systems MMSI public float $5.4B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.